The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.
Genetic background sways effects of autism-linked mutation
Null and Noteworthy: Arbaclofen results; another oxytocin edition
Dataset maps connectivity in 40,000 brains
Grafted organoids reveal how microglia adapt to shifting brain environments
Flawed protocol for levodopa clinical trial brings retractions
Trials of arbaclofen for autism yield mixed results
Medley of models reveals misbehaving pathways in autism-linked condition
Spectrum Launch: Demystifying academia with Laurel Gabard-Durnam
What kind of autism research should we do, and where should we do it?
Loss of autism-linked gene dampens social interactions in animals
Acetaminophen on trial over possible links to autism, ADHD
Company on brink takes psilocybin to trial for fragile X syndrome
U.S. study charts changing prevalence of profound and non-profound autism
A questionable study linked epidurals to autism. Then what?
Null and Noteworthy: Reader response; cerebrospinal fluid; connectivity subgroups
New measure characterizes gender diversity in study participants
Journal club: Does lithium in drinking water contribute to autism?
Rare autism-linked mutation starves growing neurons of essential nutrients
RNA therapy restores gene function in monkeys modeling Angelman syndrome
Immune molecule alters cellular makeup of human brain organoids
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Speaking of Psychology
Stuff To Blow Your Mind